American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARA | DGX | DVA | EHC | CHE |
| Company | American Renal Associates | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Encompass Health Corp | Chemed Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 11.48 | 161.32 | 161.40 | 98.48 | 551.03 |
| High | 11.52 | 164.25 | 164.87 | 99.65 | 565.40 |
| Low | 11.33 | 160.33 | 161.38 | 98.09 | 551.03 |
| Last | 11.52 | 163.89 | 164.14 | 99.40 | 563.28 |
| Change | +0.02 | +2.57 | +2.74 | +0.47 | +10.41 |
| % Change | +0.17% | +1.59% | +1.70% | +0.48% | +1.88% |
| Volume | 9,800 | 651,540 | 707,704 | 695,862 | 120,420 |
| 20-Day Average Volume | 110,105 | 870,317 | 1,021,655 | 828,318 | 111,681 |
| Previous Close | 11.50 | 161.32 | 161.40 | 98.93 | 552.87 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.47 | 158.02 | 152.93 | 100.09 | 559.08 |
| 20-Day Raw Stochastic | 100.00% | 97.05% | 97.28% | 59.19% | 44.17% |
| 20-Day Relative Strength | 70.89% | 63.42% | 58.40% | 53.88% | 47.79% |
| Weighted Alpha | -7.72 | +25.85 | +59.59 | +48.09 | -4.18 |
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | 88% Buy | 56% Sell |
| Previous Opinion | 100% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Sell |
| Last Month's Opinion | 72% Buy | 88% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 01/15/21 | +4.50% since 11/14/24 | +6.34% since 11/14/24 | -1.79% since 11/14/24 | +0.18% since 11/14/24 |
| Low | 11.33 on 01/25/21 | 156.32 on 11/15/24 | 154.05 on 11/19/24 | 97.57 on 11/19/24 | 545.75 on 11/19/24 |
| High | 11.52 on 01/25/21 | 164.25 on 11/21/24 | 164.87 on 11/21/24 | 101.55 on 11/15/24 | 565.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +0.70% since 12/24/20 | +11.21% since 10/21/24 | +1.61% since 10/21/24 | +3.81% since 10/21/24 | -6.21% since 10/21/24 |
| Low | 11.33 on 01/25/21 | 151.33 on 10/22/24 | 138.00 on 10/30/24 | 91.93 on 10/25/24 | 523.33 on 11/04/24 |
| High | 11.52 on 01/25/21 | 164.25 on 11/21/24 | 164.87 on 11/21/24 | 104.55 on 11/11/24 | 613.78 on 10/29/24 |
| 3-Month | |||||
| %Chg | +0.17% since 10/23/20 | +7.14% since 08/21/24 | +8.99% since 08/21/24 | +11.17% since 08/21/24 | -2.36% since 08/21/24 |
| Low | 11.33 on 01/25/21 | 146.17 on 10/07/24 | 138.00 on 10/30/24 | 89.43 on 08/22/24 | 523.33 on 11/04/24 |
| High | 11.52 on 01/25/21 | 164.25 on 11/21/24 | 168.50 on 10/16/24 | 104.55 on 11/11/24 | 615.65 on 10/18/24 |
| 6-Month | |||||
| %Chg | +80.56% since 07/24/20 | +14.34% since 05/21/24 | +18.35% since 05/21/24 | +15.85% since 05/21/24 | +0.62% since 05/21/24 |
| Low | 6.08 on 09/21/20 | 135.47 on 06/28/24 | 131.44 on 05/23/24 | 82.74 on 08/06/24 | 523.33 on 11/04/24 |
| High | 11.98 on 10/06/20 | 164.25 on 11/21/24 | 168.50 on 10/16/24 | 104.55 on 11/11/24 | 615.65 on 10/18/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 397,935 | 18,005,732 | 13,234,800 | 9,967,198 | 8,320,694 |
| Shares Outstanding, K | 34,543 | 111,615 | 82,000 | 100,750 | 15,050 |
| Annual Sales | 822,520,000 | 9,252,000,000 | 12,140,150,000 | 4,801,200,000 | 2,264,420,000 |
| Annual Net Income | -13,790,000 | 854,000,000 | 691,540,000 | 352,000,000 | 272,510,000 |
| Last Quarter Sales | 209,690,000 | 2,488,000,000 | 3,263,590,000 | 1,351,000,000 | 606,180,000 |
| Last Quarter Net Income | -2,690,000 | 226,000,000 | 214,690,000 | 108,200,000 | 75,780,000 |
| 60-Month Beta | 1.11 | 0.89 | 0.89 | 0.88 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.30 on 10/22/24 | 2.59 on 10/29/24 | 1.03 on 10/28/24 | 5.64 on 10/29/24 |
| Latest Earnings Date | 03/15/21 | 10/22/24 | 10/29/24 | 10/28/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.750 on 10/04/24 | N/A | 0.170 on 10/01/24 | 0.500 on 11/18/24 |
| Next Ex-Dividends Date | N/A | 01/14/25 | N/A | 01/02/25 | 11/18/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.23 | 16.65 | 23.54 | 25.32 |